Kaiser Permanente Cafeteria

The Glaucoma Research Foundation (GRF) is a non-profit organization based in San Francisco, CA, dedicated to finding a cure for glaucoma and restoring vision through innovative research. With over 40 years of experience, the GRF has been working tirelessly to improve the lives of people living with glaucoma, enhance glaucoma care and treatment, and accelerate progress towards a cure. Their multidisciplinary consortium of researchers, known as Catalyst for a Cure, collaborates to expedite the development of a cure for glaucoma and the restoration of vision. Through their research grants and pilot projects, the GRF provides seed funding for promising research initiatives in the field of glaucoma. In addition to their research efforts, the GRF offers a range of resources and support for individuals diagnosed with glaucoma. Whether it's finding a doctor, joining a support group, or accessing educational materials, the GRF is committed to helping patients navigate their glaucoma journey. They also organize various events, such as the Glaucoma 360 Annual Gala, the Glaucoma Patient Summit, and the New Horizons Forum, which bring together experts, industry leaders, and patients to discuss advancements in glaucoma treatment and research innovation. Through their dedication to sight-saving research and their commitment to improving the lives of those affected by glaucoma, the GRF continues to make a significant impact in the fight against this sight-threatening disease.Generated from the website

Natera is a leading molecular diagnostics company based in San Carlos, CA. They specialize in providing noninvasive cell-free DNA tests that help inform personalized healthcare decisions. Their tests measure fetal, tumor, or donor cfDNA at the molecular level, allowing for the identification of disease risk, detection of recurrence, and understanding of treatment responses. Natera is dedicated to advancing healthcare in the fields of oncology, women's health, and organ health, offering innovative solutions that enable more informed health decisions for individualized care. With a commitment to integrity and scientific rigor, Natera is at the forefront of molecular diagnostics innovation. Their oncology tests allow for the characterization of tumors, anticipation of risk, and evaluation of treatment response earlier than traditional tools. In the field of women's health, Natera's tests help identify the risk of severe genetic conditions, enabling families to prepare and inform early intervention for improved outcomes. Additionally, their organ health tests detect organ injury early and inform treatment strategies to enhance transplant health. Natera's dedication to innovation and integrity sets them apart as a trusted provider of molecular diagnostic solutions.Generated from the website